Abstract:AIM: To provide the expression profile of serine protease SNC19/matriptase and its inhibitor hepatocyte growth factor activator inhibitor type 1 (HAI-1) in normal and malignant tissues of gastrointestinal tract at mRNA level for further study on their correlations with tumor progression and metastasis. METHODS: Total RNAs were prepared from 37 samples of colorectal cancer tissues, 40 samples of gastric cancer tissues, and their adjacent normal tissues. The expression of SNC19/matriptase and HAI-1 in these samples was detected by real-time fluorescent quantitative PCR using glyceraldehyde-3-phosphate dehydrogenase as internal standard, and the clinical significance for the correlation with clinicopathological parameters was evaluated. RESULTS: In gastric cancer tissues the expression of HAI-1 and SNC19/matriptase was significantly lower than that in the corresponding adjacent normal tissues (Z = -3.280, P = 0.006; Z = -4.651, P = 0.000). HAI-1: SNC19/matriptase ratio showed no difference between normal and malignant tissues (P>0.05). Analysis of clinicopathological parameters showed decreased expression of HAI-1 and HAI-1: SNC19/matriptase ratio associated with stage III/IV gastric tumors as compared to stage I/II ones (Z = -2.140, P = 0.031; Z = -2.155, P = 0.031), and with lymph node-positive gastric cancer tissues as compared to lymph node-negative ones (Z = -2.081, P = 0.036; Z = -2.686, P = 0.006). The expression of SNC19/matriptase had no relationship with stages and lymph node metastasis (P>0.05). The expression of HAI-1 and HAI-1: SNC19/matriptase ratio increased in well-differentiated gastric cancer tissues, but there was no statistical significance (P>0.05). The difference of SNC19/matriptase expression was not significant in gastric cancer tissues of different histological differentiation status (P>0.05). In colorectal cancer tissues, the expression of HAI-1 and SNC19/matriptase was also markedly lower than that in their adjacent normal tissues (Z = -3.100, P = 0.002; Z = -2.731, P = 0.006), whereas HAI-1: SNC19/matriptase ratio showed no difference. Decreased expression of HAI-1 was associated with increased invasive depth and lymph node metastasis, but there was no statistical significance (P>0.05). The difference of SNC19/matriptase expression and HAI-1: SNC19/matriptase ratio was not significant in different stages and different lymph node metastasis status (P>0.05). The expression of SNC19/matriptase, HAI-1 or HAI-1: SNC19/matriptase ratio showed no difference in colorectal cancer tissues of different histological differentiation status (P>0.05). CONCLUSION: The expressions of SNC19/matriptase and its inhibitor HAI-1 are decreased in gastrointestinal cancer tissues compared to their normal counterparts, and the decreased expression of HAI-1 may correlate with invasion and lymph node metastasis. The possible mechanisms involved need to be further investigated. (C) 2005 The WJG Press and Elsevier Inc. All rights reserved.

Expression of HAI-1 in Normal Tissues and Malignancies and Its Clinical Significance in Colorectal Cancer

Down-regulation of HAI-1 is Associated with Poor-Differentiation Status of Colorectal Cancer

HOTAIRM1 as a potential biomarker for diagnosis of colorectal cancer functions the role in the tumour suppressor

Expression of serine protease SNC19/matriptase and its inhibitor hepatocyte growth factor activator inhibitor type 1 in normal and malignant tissues of gastrointestinal tract.

Expression of HSP90 and HIF-1α in Human Colorectal Cancer Tissue and Its Significance

Prognostic significance of hepatocyte growth factor activator inhibitor type 1 (HAI-1) immunoreactivity in pancreatic ductal adenocarcinoma

Clinical Significance of Immunohistochemical Expression of Hypoxia-Inducible Factor–1α As a Prognostic Marker in Rectal Adenocarcinoma

Expression Characteristics of Heparanase in Colon Carcinoma and Its Close Relationship with Cyclooxygenase-2 and Angiogenesis.

Significance of Tiam1 and SNAI1 in EMT of Human Colorectal Carcinoma

Expressions of HIF-1α and CDX2 and Its Clinical Pathological Significance in Colorectal Adenocarcinoma

The significance of HAUS1 and its relationship with immune microenvironment in hepatocellular carcinoma

Hiwi Expression Profile In Cancer Cells And Its Prognostic Value For Patients With Colorectal Cancer

Expression of HtrA1 in cervical intraepithelial neoplasm and cervical cancer

HGC - 1 expression in gastric carcinoma and its relationship with clinicopathological fac-tors and prognosis

Expression Pattern and Clinical Significance of Hairy Enhancer of Split 1 in Colorectal Cancer

Expression of HSP 90 and HIF-1 毩 in human colorectal cancer tissue and its significance

Expression of ALDH1 in cervical carcinoma and its significance

Expression of Hedgehog Signaling Pathway Members in Colon Cancer and Their Clinical Significances

Expression and analysis of HIC-1 and HMMR in breast cancer

The Expressions of Hypoxia-Inducible Factor-1Α and Cell Adhesion Molecules in Pancreatic Adenocarcinoma and Their Clinical Significance

Human Apurinic Endonuclease 1 Expression in a Colorectal Adenoma-Carcinoma Sequence.